glp-1 education Therapy Part 2: Preventing and Managing Side Effects – Sarah Hormachea The GLP-1 revolution: What UAB

But with Jennifers help, it happened

BCA, Bis-creatine

KLOW peptide arrives as lyophilized powder requiring reconstitution with bacteriostatic water

( a ) HPLC-TOF chromatogram, UV 214 nm

Because the medication goes straight into your system, the effects are consistent and predictable, which is why these injections have such strong clinical evidence behind them

Key properties: Stimulates GH release from the pituitary (not the hypothalamus) Does not significantly raise cortisol or prolactin Short half-life (~2 hours) produces a sharp, pulsatile GH release Does not block somatostatin (the hormone that inhibits GH release) Selective for GH minimal effect on other hormones The selectivity is what makes ipamorelin the preferred GHRP for most protocols